But according to this link there are 11 :eek: in the county.

 

pharmacies in Clay County, KY | Reviews - Yellowbook

 

1. Rite Aid

2. Clay Community Pharmacy

3. Clay Discount Drug

4. Clinic Pharmacy

5. Family Drug Center (Bridge Street)

6. Family Drug Center (Manchester Shopping Center)

7. H&N Drug

8. Home Town Pharmacy

9. Infusion Care of Southeast Kentucky

10. Manchester Pharmacy

11. Morgan's Professional Pharmacy

 

You can probably add any large grocery or walmart type chains that may be there.

So here's my question. Pseudoephedrine purchases are tracked and people are able to purchase only a certain quantity in a certain time frame. In a previous discussion about this it was also implied that if a person made several attempts to purchase outside of their buying window, their name could be turned over to law enforcement. We still have an issue with meth even with all those safeguards, but that's another discussion. Why couldn't that sort of system be set up for opioids?

 

Opioids are prescribed by doctors and there is no cost efficent way for the government to oversee every diagnosis, not would I want them to.

KY has one called KASPER that MDs and pharmacies are supposed to use. MDs are supposed to run a KASPER report before prescribing any controlled substances (not just opiods). Pharmacies then report the details of the fill to KASPER so the database is up to date. If you were ever asked for a SS# when picking up or dropping off a medication in KY that was due KY's KASPER requirements.

 

Pseudoephedrine is not a prescription only medication and as such they can track all purchases through methcheck which is nationwide. The US is a patchwork of drug laws that very from state to state and not all drugs are even under the same restrictions from state to state.

 

Good post. To piggy back off this, the law says that prescribers are supposed to run a KASPER on every patient before writing for a control and most do abide by this practice but plenty do not. On the pharmacy side, we are not legally required to run one but most do if they suspect something or if they are a completely and unknown patient. Kroger has their own report that pulls from KASPER and other states they operate in which saves us time to look at the info. Depending on the dose or other meds they are on, Kroger requires it’s pharmacist to look at the report before processing the script.

 

However each state operates their own KASPER-like controlled medication reports and the downfall of many of these is that they don’t communicate with one another which could be a potential abuse point for areas on state borders as they could fill the same script on both sides at different pharmacies and pharmacy’s wouldn’t know. That being said, there are red flags we may identify like patient requesting to pay cash, etc that may catch our attention and we may deny their fill.

I just got home from a training class for an EHR program used by a hospitalist group I am doing IT work for. One of the topics covered was the new Florida Law requiring practitioners and pharmacists to join and utilize the upgraded E-FORCISE system, which expands the use of the Prescription Drug Monitoring Program started in 2013. The law takes affect July 1 and doctors who have not registered for E-FORCISE by that time will not be able to prescribe Schedule II opioids until they do.

 

In summary, the new law:

 

* Requires all practitioners who have a DEA number and are authorized to prescribe controlled substances to complete a board approved 2-hour CME course offered by a statewide professional association of physicians in Florida accredited to provide AMA Category 1 (or American Osteopathic Category 1-A) CME credit as part of their biennial license renewal. This course must be completed by January 31, 2019, and at each subsequent renewal.

 

* Limits the prescription for a Schedule II opioid for acute pain to a 3-day supply, or a 7-day supply if deemed medically necessary by the prescriber and with proper documentation. The definition of acute pain excludes pain related to cancer, terminal illness, palliative care, and serious traumatic injury with an Injury Severity Score (ISS) of 9 or greater.

 

* Requires a concurrent prescription for an emergency opioid antagonist with the prescription of Schedule II controlled substances for the treatment of pain related to a serious traumatic injury with an ISS of 9 or greater.

 

* Requires regulatory boards within the Department of Health to establish guidelines for prescribing controlled substances for acute pain.

 

* Requires healthcare providers to review a patient’s PDMP history before prescribing or dispensing a controlled substance, with limited exemptions.

 

* Authorizes a dispensing practitioner to dispense Schedule II and III substances that have been approved by the FDA for treating opiate addictions to the practitioner’s own patients for the medication-assisted treatment of opiate addiction.

 

* Adds substances to the definitions of Schedule II, Schedule III, Schedule IV, and Schedule V and requires that Schedule V substances must be reported to the PDMP.

 

* Authorizes electronic prescriptions for controlled substances.

 

* Requires pharmacists and dispensing physicians to verify a patient’s identity prior to dispensing controlled substances.

 

It's got a lot of people upset.

 

ALERT – New Florida Opioid Law | MagMutual

Here is a related story. An artist was arrested Friday when he placed an 800lb steel sculpture, of a burnt heroin spoon, in the car drop off lane of Purdue Phatma. Purdue Pharma is majority owned by the developers of OxyContin. I say well done on getting your name out there and a nice peaceful protest.

 

Gallery Owner Arrested After Dropping Sculpture Of Giant Drug Spoon At Purdue Pharma - Hartford Courant